| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.52B | +85.5% |
| Cost of Revenue | $1.25B | +84.8% |
| Gross Profit | $1.27B | +86.3% |
| R&D Expense | $2.4M | +140.0% |
| SG&A Expense | $798.8M | +52.3% |
| Operating Income | $141.1M | -9.4% |
| Pre-tax Income | $125.0M | -35.9% |
| Income Tax | $17.0M | -65.9% |
| Net Income | $108.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $398.9M | -55.2% |
| Accounts Receivable | $755.5M | +179.5% |
| Inventory | $337.7M | +157.5% |
| Current Assets | $1.81B | +36.7% |
| Total Assets | $5.12B | +189.8% |
| Current Liabilities | $1.08B | +195.1% |
| Long-term Debt | $676.9M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $359.4M | +36.7% |
| Capital Expenditures | $36.1M | +54.2% |
| Investing Cash Flow | -$1.30B | -1173.7% |
| Financing Cash Flow | $582.8M | +2344.3% |
| Free Cash Flow | $323.4M | +35.0% |
| -25.6% |
| EPS (Basic) | $0.25 | -45.7% |
| EPS (Diluted) | $0.25 | -44.4% |
| Total Liabilities |
| $2.18B |
| +301.5% |
| Stockholders' Equity | $1.18B | +195.4% |